Bone sarcomas in 239Pu-treated mice.

Area of Science:

• Radiobiology
• Oncology
• Toxicology

Background:

• Plutonium-239 (239Pu) is a radioactive element with known health risks.
• Understanding the long-term effects of internal 239Pu contamination on bone is crucial for risk assessment.

Purpose of the Study:

• To investigate the incidence and characteristics of bone sarcomas induced by chronic exposure to monomeric 239Pu in female ICR mice.
• To evaluate the relationship between retained 239Pu activity, skeletal dose, and osteosarcoma development.

Main Methods:

• Female ICR mice were injected with 180.1 kBq/kg of monomeric 239Pu at 10 weeks of age.
• Survival rates and tumor incidence were monitored over the long term.
• Tumor type, location, and presence of metastases were histologically analyzed.
• Osteosarcoma incidence was correlated with cumulative skeletal dose.

Main Results:

• A significant increase in bone sarcoma incidence was observed in 239Pu-exposed mice compared to controls.
• The majority of induced sarcomas were osteoblastic osteosarcomas, predominantly located in the spine and trabecular bone.
• Metastases were observed in several organs in a subset of tumor-bearing mice.
• A single osteogenic sarcoma was found in the control group.

Conclusions:

• Chronic internal exposure to 239Pu induces a high incidence of bone sarcomas, particularly osteosarcomas.
• The location and type of induced tumors are consistent with known plutonium deposition patterns in bone.
• The findings contribute to understanding the long-term oncogenic effects of plutonium exposure.